Work

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Year: 2017

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: American Journal of Nephrology

DOI: 10.1159/000481736

Authors: Matthew R. Weir, Pablo E. Pergola, Rajiv Agarwal, Jeffrey C. Fink, Nelson P. Kopyt, Ajay K. Singh, Jayant Kumar, Susanne Schmitt, Gregor Schaffar, Anita Rudy, Jim P. McKay, Radmila Kanceva

Institutions: University of Maryland, Baltimore, The University of Texas at San Antonio Health Science Center, Renal Associates P. A., Indiana University School of Medicine, Lehigh Valley Hospital, Harvard University, Hexal (Germany), Sandoz Group AG (Switzerland)

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2765107931

FWCI: 1.433

Cites: 4

Cited by: 12

Related to: 10